Fc portion of intravenous immunoglobulin suppresses the induction of experimental allergic neuritis

Journal of Neuroimmunology

Volumn 78, Issue 1-2, 1997, Pages 127-131

  Miyagi, Fuminori ^a   Horiuchi, Hideki ^a   Nagata, Ikuo ^a   Kitahara, Shigehisa ^a   Kiyoki, Mamoru ^a   Komoriya, Keiji ^a   Yuki, Nobuhiro ^b  

^a Pharmacological Research Department   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Experimental allergic neuritis; Fc; Guillain Barre syndrome; Intravenous immunoglobulin

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT;

ACTIVE IMMUNIZATION; ALLERGIC NEUROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFICACY; EFFECTOR CELL; GENE INDUCTION; GUILLAIN BARRE SYNDROME; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES; CATTLE; IMMUNIZATION; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MYELIN P2 PROTEIN; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW;

EID: 0030774898     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00090-8     Document Type: Article

References (11)

1. Achiron A., Margalit R., Hershkoviz R., Markoviz D., Reshef T., Melamed E., Cohen I.R., Lider O. Intravenous immunoglobulin treatment of experimental T-cell-mediated autoimmune disease. J. Clin. Invest. 93:1994;600-605.
2. Achiron A., Gilad R., Margalit R., Gabbay U., Sarova-Pinhas I., Cohen I.R., Melamed E., Lider O., Noy S., Ziv I. Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: Delineation of usage and mode of action. J. Neurol. Neurosurgery. Psychiatry. 57 (Suppl.):1994;57-61.
3. Asbury A.K., McKhann G.M. Changing views of Guillain-Barr syndrome. Ann. Neurol. 41:1997;287-288.
4. Dwyer J.M. Manipulating the immune system with immune globulin. N. Engl. J. Med. 326:1992;107-116.
5. Malik U., Oleksowicz L., Latov N., Cardo L.J. Intravenous γ-globulin inhibits binding of anti-GM1 to its target antigen. Ann. Neurol. 39:1996;136-139.
6. 2 protein. J. Neuroimmunol. 4:1983;105-117.
7. Nardella F.A., Teller D.C. Fc intermediate (Fci), a papain-generated fragment of human IgG, intermediate in charge, molecular weight and cleavage between the Fc and Fc′ fragments of IgG. Mol. Immunol. 22:1985;705-713.
8. 2 protein. J. Neuroimmunol. 30:1990;145-151.
9. Thornton C.A., Griggs R.C. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann. Neurol. 35:1994;260-268.
10. Yuki N., Miyagi F. Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathies. J. Neurol. Sci. 139:1996;160-162.
11. van der Meché, F.G.A., Schmitz, P.I.M., and the Dutch Guillain-Barr Study Group, 1992. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N. Engl. J. Med. 326, 1123-1129.